Alessio De Rose: Addressing Micronutrient Deficiencies in the Era of GLP-1 Receptor Agonists
Alessio De Rose, Nutrition Manager at S.S. Lazio, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Nutrients, adding:
“I am thrilled to share our recently published article in Nutrients:
‘Ironing Out Possible Micronutrient Deficiencies Associated with Incretin Receptor Agonist-Based Therapies: Proposed Practical Strategies to Prevent and Manage Iron Deficiency’
Incretin receptor agonist-based therapies, including GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists, have significantly changed the management of type 2 diabetes, overweight, and obesity.
As their clinical use continues to expand, it is becoming increasingly important to consider not only their metabolic benefits, but also their potential nutritional implications.
In this perspective article, we discuss emerging evidence on the possible association between incretin-based therapies and iron deficiency/iron deficiency anemia, explore the potential underlying mechanisms, and propose practical strategies for prevention, biochemical monitoring, and clinical-nutritional management.
This work highlights the importance of integrating pharmacological innovation with careful nutritional assessment and individualized patient care.
I am grateful to all co-authors and collaborators for their valuable contribution to this work.”
Title: Ironing Out Possible Micronutrient Deficiencies Associated with Incretin Receptor Agonist-Based Therapies: Proposed Practical Strategies to Prevent and Manage Iron Deficiency
Authors: Marco Infante, Camillo Ricordi, Francesca Pacifici, Donatella Pastore, Raffaele Infante, Massimiliano Caprio, Francesca Chiereghin, Alessandro De Stefano, Giulia Frank, Alessio De Rose, Lorenzo Romano, Laura Di Renzo, Valentina Rovella, Antonino De Lorenzo, Giulia Donadel, David Della-Morte
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering